{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T15:48:48Z","timestamp":1790696928524,"version":"4.1.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"33","license":[{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"US National Institute of Allergy and Infectious Disease","award":["5R21AI115205"],"award-info":[{"award-number":["5R21AI115205"]}]},{"name":"Department of Epidemiology","award":["UL1TR001111"],"award-info":[{"award-number":["UL1TR001111"]}]},{"DOI":"10.13039\/100007327","name":"UNC Gillings School of Global Public Health","doi-asserted-by":"crossref","award":["2015213"],"award-info":[{"award-number":["2015213"]}],"id":[{"id":"10.13039\/100007327","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100005539","name":"Cecil G. Sheps Center for Health Services Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005539","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006808","name":"UNC","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006808","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000862","name":"Doris Duke Charitable Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000862","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1016\/j.vaccine.2017.06.071","type":"journal-article","created":{"date-parts":[[2017,6,29]],"date-time":"2017-06-29T20:30:57Z","timestamp":1498768257000},"page":"4072-4078","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":54,"title":["Prenatal Tdap immunization and risk of maternal and newborn adverse events"],"prefix":"10.1016","volume":"35","author":[{"given":"J. Bradley","family":"Layton","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne M.","family":"Butler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongmei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim A.","family":"Boggess","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Weber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leah J.","family":"McGrath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvia","family":"Becker-Dreps","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2017.06.071_b0005","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1086\/421033","article-title":"Prevalence of pertussis antibodies in maternal delivery, cord, and infant serum","volume":"190","author":"Healy","year":"2004","journal-title":"J Inf Dis"},{"key":"10.1016\/j.vaccine.2017.06.071_b0010","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1093\/cid\/cis923","article-title":"Importance of timing of maternal combined tetanus, diphtheria, and acellular pertussis (Tdap) immunization and protection of young infants","volume":"56","author":"Healy","year":"2013","journal-title":"Clin Inf Dis: Official Pub Inf Dis Soc Am"},{"key":"10.1016\/j.vaccine.2017.06.071_b0015","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1097\/INF.0b013e3182093814","article-title":"Effect of a prepregnancy pertussis booster dose on maternal antibody titers in young infants","volume":"30","author":"Leuridan","year":"2011","journal-title":"The Pediatric infectious disease journal."},{"key":"10.1016\/j.vaccine.2017.06.071_b0020","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1093\/cid\/ciw634","article-title":"Effectiveness of Prenatal Versus Postpartum Tetanus, Diphtheria, and Acellular Pertussis Vaccination in Preventing Infant Pertussis","volume":"64","author":"Winter","year":"2017","journal-title":"Clin Inf Dis: Official Pub Inf Dis Soc Am"},{"key":"10.1016\/j.vaccine.2017.06.071_b0025","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1093\/aje\/kwv347","article-title":"Cost-Effectiveness of Pertussis Vaccination During Pregnancy in the United States","volume":"183","author":"Atkins","year":"2016","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.vaccine.2017.06.071_b0030","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1093\/cid\/ciu821","article-title":"A case-control study to estimate the effectiveness of maternal pertussis vaccination in protecting newborn infants in England and Wales, 2012\u20132013","volume":"60","author":"Dabrera","year":"2015","journal-title":"Clin Inf Dis: Official Pub Inf Dis Soc Am"},{"key":"10.1016\/j.vaccine.2017.06.071_b0035","unstructured":"Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine (Tdap) in pregnant women--Advisory Committee on Immunization Practices (ACIP), 2012. MMWR Morbidity and mortality weekly report. 2013;62:131\u20135."},{"key":"10.1016\/j.vaccine.2017.06.071_b0040","unstructured":"RCOG statement: Pertussis (whooping cough) vaccination now offered from 20 weeks of pregnancy. London: Royal College of Obstetricians and Gynaecologists; 2016."},{"key":"10.1016\/j.vaccine.2017.06.071_b0045","unstructured":"4.12 Pertussis. The Australian Immunisation Handbook 10th Edition: Australian Government Department of Health; 2016."},{"key":"10.1016\/j.vaccine.2017.06.071_b0050","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/j.vaccine.2015.12.046","article-title":"Maternal Tdap vaccination: Coverage and acute safety outcomes in the vaccine safety datalink, 2007\u20132013","volume":"34","author":"Kharbanda","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.06.071_b0055","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.ypmed.2014.05.025","article-title":"Receipt of pertussis vaccine during pregnancy across 7 Vaccine Safety Datalink sites","volume":"67","author":"Kharbanda","year":"2014","journal-title":"Prev Med"},{"key":"10.1016\/j.vaccine.2017.06.071_b0060","first-page":"746","article-title":"Pertussis and Influenza Vaccination Among Insured Pregnant Women - Wisconsin, 2013\u20132014","volume":"64","author":"Koepke","year":"2015","journal-title":"MMWR Morbidity and Mortality Weekly Report"},{"key":"10.1016\/j.vaccine.2017.06.071_b0065","first-page":"839","article-title":"Vaccination with tetanus, diphtheria, and acellular pertussis vaccine of pregnant women enrolled in Medicaid-Michigan, 2011\u20132013","volume":"63","author":"Housey","year":"2014","journal-title":"MMWR Morbidity and Mortality Weekly Report"},{"key":"10.1016\/j.vaccine.2017.06.071_b0070","doi-asserted-by":"crossref","DOI":"10.1097\/AOG.0000000000001927","article-title":"Predictors of low uptake of prenatal tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis immunization in privately insured women in the United States","author":"Butler","year":"2017","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.vaccine.2017.06.071_b0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajic.2016.11.025","article-title":"Despite awareness of recommendations, why do health care workers not immunize pregnant women?","author":"Gesser-Edelsburg","year":"2017","journal-title":"Am J Inf Contr"},{"key":"10.1016\/j.vaccine.2017.06.071_b0080","article-title":"Factors associated with intention to receive influenza and tetanus, diphtheria, and acellular pertussis (Tdap) vaccines during pregnancy: a focus on vaccine hesitancy and perceptions of disease severity and vaccine safety","volume":"7","author":"Chamberlain","year":"2015","journal-title":"PLoS currents"},{"key":"10.1016\/j.vaccine.2017.06.071_b0085","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1097\/AOG.0000000000001888","article-title":"Safety of tetanus, diphtheria, and pertussis vaccination during pregnancy: a systematic review","volume":"129","author":"McMillan","year":"2017","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.vaccine.2017.06.071_b0090","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1001\/jama.2014.14825","article-title":"Evaluation of the association of maternal pertussis vaccination with obstetric events and birth outcomes","volume":"312","author":"Kharbanda","year":"2014","journal-title":"Jama"},{"key":"10.1016\/j.vaccine.2017.06.071_b0095","doi-asserted-by":"crossref","first-page":"136","DOI":"10.15585\/mmwr.mm6605e2","article-title":"Advisory committee on immunization practices recommended immunization schedule for adults aged 19 years or older - United States, 2017","volume":"66","author":"Kim","year":"2017","journal-title":"MMWR Morbidity and Mortality Weekly Report"},{"key":"10.1016\/j.vaccine.2017.06.071_b0100","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1097\/DBP.0b013e3181e5ac93","article-title":"Use of antidepressants during pregnancy and risk of attention-deficit\/hyperactivity disorder in the offspring","volume":"31","author":"Figueroa","year":"2010","journal-title":"J Dev Behav Pediat: JDBP"},{"key":"10.1016\/j.vaccine.2017.06.071_b0105","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1001\/jamapediatrics.2015.74","article-title":"Association of adverse pregnancy outcomes with glyburide vs insulin in women with gestational diabetes","volume":"169","author":"Camelo Castillo","year":"2015","journal-title":"JAMA Pediat"},{"key":"10.1016\/j.vaccine.2017.06.071_b0110","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1002\/pds.3407","article-title":"Validation of an algorithm to estimate gestational age in electronic health plan databases","volume":"22","author":"Li","year":"2013","journal-title":"Pharmacoepidemiol Drug Safety."},{"key":"10.1016\/j.vaccine.2017.06.071_b0115","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1002\/pds.3743","article-title":"Beginning and duration of pregnancy in automated health care databases: review of estimation methods and validation results","volume":"24","author":"Margulis","year":"2015","journal-title":"Pharmacoepidemiol Drug Safety"},{"key":"10.1016\/j.vaccine.2017.06.071_b0120","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1002\/pds.3284","article-title":"Algorithms to estimate the beginning of pregnancy in administrative databases","volume":"22","author":"Margulis","year":"2013","journal-title":"Pharmacoepidemiol Drug Safety"},{"key":"10.1016\/j.vaccine.2017.06.071_b0125","unstructured":"Centers for Disease Control and Prevention. VFC Childhood Vaccine Supply Policy 2009. 2009."},{"key":"10.1016\/j.vaccine.2017.06.071_b0130","doi-asserted-by":"crossref","first-page":"9404","DOI":"10.1016\/j.vaccine.2011.05.100","article-title":"Adverse events after tetanus toxoid, reduced diphtheria toxoid and acellular pertussis (Tdap) vaccine administered to adults 65 years of age and older reported to the Vaccine Adverse Event Reporting System (VAERS), 2005\u20132010","volume":"29","author":"Moro","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.06.071_b0135","doi-asserted-by":"crossref","first-page":"8001","DOI":"10.1016\/j.vaccine.2010.09.034","article-title":"The safety of immunizing with tetanus-diphtheria-acellular pertussis vaccine (Tdap) less than 2 years following previous tetanus vaccination: experience during a mass vaccination campaign of healthcare personnel during a respiratory illness outbreak","volume":"28","author":"Talbot","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.06.071_b0140","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1016\/j.vaccine.2013.02.009","article-title":"Algorithms for identification of Guillain-Barre Syndrome among adolescents in claims databases","volume":"31","author":"Funch","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.06.071_b0145","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1161\/CIRCOUTCOMES.113.000359","article-title":"Propensity score methods for confounding control in nonexperimental research","volume":"6","author":"Brookhart","year":"2013","journal-title":"Circulation Cardiovascular Quality and Outcomes"},{"key":"10.1016\/j.vaccine.2017.06.071_b0150","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1093\/aje\/kwn164","article-title":"Constructing inverse probability weights for marginal structural models","volume":"168","author":"Cole","year":"2008","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.vaccine.2017.06.071_b0155","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1093\/aje\/kwq198","article-title":"Treatment effects in the presence of unmeasured confounding: dealing with observations in the tails of the propensity score distribution\u2013a simulation study","volume":"172","author":"Sturmer","year":"2010","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.vaccine.2017.06.071_b0160","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1016\/j.vaccine.2016.01.058","article-title":"Trends in reasons for non-receipt of influenza vaccination during pregnancy in Georgia, 2004\u20132011","volume":"34","author":"Chamberlain","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.06.071_b0165","doi-asserted-by":"crossref","first-page":"S124","DOI":"10.1016\/j.ajog.2011.04.011","article-title":"Predictors of H1N1 vaccination in pregnancy","volume":"204","author":"Fridman","year":"2011","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.vaccine.2017.06.071_b0170","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s40471-015-0053-5","article-title":"The active comparator, new user study design in pharmacoepidemiology: historical foundations and contemporary application","volume":"2","author":"Lund","year":"2015","journal-title":"Current Epidemiol Reports."},{"key":"10.1016\/j.vaccine.2017.06.071_b0175","doi-asserted-by":"crossref","first-page":"g4219","DOI":"10.1136\/bmj.g4219","article-title":"Safety of pertussis vaccination in pregnant women in UK: observational study","volume":"349","author":"Donegan","year":"2014","journal-title":"Bmj."},{"key":"10.1016\/j.vaccine.2017.06.071_b0180","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1097\/AOG.0000000000000862","article-title":"Pregnancy outcomes after antepartum tetanus, diphtheria, and acellular pertussis vaccination","volume":"125","author":"Morgan","year":"2015","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.vaccine.2017.06.071_b0185","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1080\/21645515.2016.1157241","article-title":"Maternal and infant outcomes among women vaccinated against pertussis during pregnancy","volume":"12","author":"Berenson","year":"2016","journal-title":"Human Vaccines & Immunotherap"},{"key":"10.1016\/j.vaccine.2017.06.071_b0190","doi-asserted-by":"crossref","first-page":"8982","DOI":"10.1016\/j.vaccine.2011.09.039","article-title":"Inflammatory responses to trivalent influenza virus vaccine among pregnant women","volume":"29","author":"Christian","year":"2011","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X1730868X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X1730868X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,31]],"date-time":"2018-08-31T00:20:00Z","timestamp":1535674800000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X1730868X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":38,"journal-issue":{"issue":"33","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["S0264410X1730868X"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.06.071","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prenatal Tdap immunization and risk of maternal and newborn adverse events","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.06.071","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}